Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 1/20 | 1.00 |
| ▸ | ADRA2B | P18089 | 1/20 | 1.00 |
| ▸ | ADRA2C | P18825 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.66 |
| ▸ | MEN1 | O00255 | 2/20 | 0.66 |
| ▸ | MAPT | P10636 | 5/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | IGF1R | P08069 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | GFER | P55789 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dropropizine SCHEMBL8379428 | 1.00 | ADRA2A (1.00) | ADRA2AADRA2BADRA2CKMT2AMEN1 | |
| Dropropizine SCHEMBL93975 | 1.00 | ADRA2A (1.00) | ADRA2AADRA2BADRA2CKMT2AMEN1 | |
| Dropropizine SCHEMBL27495915 | 0.98 | ADRA2A (0.97) | ADRA2AADRA2BADRA2CKMT2AMEN1 | |
| Dropropizine SCHEMBL10445730 | 0.91 | ADRA2A (0.83) | ADRA2AADRA2BADRA2CKMT2AMEN1 | |
| Dropropizine SCHEMBL10445733 | 0.90 | ADRA2A (0.81) | ADRA2AADRA2BADRA2CKMT2AMEN1 | |
| Dropropizine SCHEMBL10445975 | 0.90 | ADRA2A (0.81) | ADRA2AADRA2BADRA2CKMT2AMEN1 | |
| Dropropizine SCHEMBL10446140 | 0.90 | ADRA2A (0.81) | ADRA2AADRA2BADRA2CKMT2AMEN1 | |
| Dropropizine SCHEMBL10446134 | 0.90 | ADRA2A (0.81) | ADRA2AADRA2BADRA2CKMT2AMEN1 | |
| Dropropizine SCHEMBL10445732 | 0.90 | ADRA2A (0.81) | ADRA2AADRA2BADRA2CKMT2AMEN1 | |
| Dropropizine SCHEMBL10445734 | 0.85 | ADRA2A (0.72) | ADRA2AADRA2BADRA2CKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1574 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250255781-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-14 | — | — | US | claimed |
| WO-2025150072-A1 | A STABLE ORAL PRO-DISPERSION FORMULATION AND IMPLEMENTATIONS THEREOF | PULSE PHARMACEUTICALS PVT LTD (IN) | 2025-07-17 | — | — | WO | claimed |
| US-20250191770-A1 | COMPUTERIZED DECISION SUPPORT TOOL AND MEDICAL DEVICE FOR RESPIRATORY CONDITION MONITORING AND CARE | PFIZER INC. (US) | 2025-06-12 | — | — | US | claimed |
| US-12296043-B2 | Liquisoft capsules | PATHEON SOFTGELS INC. (US) | 2025-05-13 | — | — | US | claimed |
| CN-119947988-A | Porous carbon material, method for producing same, positive electrode comprising carbon material as positive electrode active material, and lithium secondary battery | 株式会社LG新能源 | 2025-05-06 | — | — | CN | claimed |
| CN-116381123-B | Method for determining substances contained in levodropropizine raw material, capsule and tablet | 湖南省药品检验检测研究院 | 2025-04-25 | — | — | CN | claimed |
| EP-4510999-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | Bristol-Myers Squibb Company (US) | 2025-02-26 | — | — | EP | claimed |
| CN-119322127-A | Method for detecting related substances of levodropropizine oral solution | 南京斯泰尔医药科技有限公司 | 2025-01-17 | — | — | CN | claimed |
| US-20240165020-A1 | LIQUISOFT CAPSULES | PATHEON SOFTGELS INC (US) | 2024-05-23 | — | — | US | claimed |
| EP-4360653-A2 | LIQUISOFT CAPSULES | Patheon Softgels Inc. (US) | 2024-05-01 | — | — | EP | claimed |
| US-20060018934-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2006-01-26 | — | — | US | claimed |
| US-20060018933-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2006-01-26 | — | — | US | claimed |
| CN-1520820-A | Slow release levodropropizine pharmaceutical composition | 王志刚 | 2004-08-18 | — | — | CN | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
| US-6069172-A | ADMINISTERING THE ENANTIOMER (R)-KETOPROFEN AND OF ITS SALTS WITH SUITABLE ORGANIC AND INORGANIC BASES IN THE THERAPY OF NEUTROPHIL-DEPENDENT DISEASES | DOMPE' SPA (IT) | 2000-05-30 | — | — | US | claimed |
| EP-0935961-A2 | (R)-2-(3-Benzoylphenyl)propionic acid salts and pharmaceutical preparations containing them | Dompé S.P.A. (IT) | 1999-08-18 | — | — | EP | claimed |
| EP-0575776-B1 | A process for the preparation of enantiomers of dropropizine | BIDACHEM SPA (IT) | 1999-03-31 | — | — | EP | claimed |
| EP-0703893-A1 | SALTS OF 2-(3-BENZOYLPHENYL) PROPIONIC ACID WITH ACHIRAL AND CHIRAL ORGANIC BASES AND PHARMACEUTICAL COMPOSITIONS THEREOF | DOMPE FARMACEUTICI S.P.A. (IT) | 1996-04-03 | — | — | EP | claimed |
| WO-1994020449-A1 | SALTS OF 2-(3-BENZOYLPHENYL)PROPIONIC ACID WITH ACHIRAL AND CHIRAL ORGANIC BASES AND PHARMACEUTICAL COMPOSITIONS THEREOF | DOMPE'FARMACEUTICI SPA (IT) | 1994-09-15 | — | — | WO | claimed |
| EP-0348713-A1 | (R,S)-3-(4-phenyl-1-piperazinyl)-1,2-propanediol salts | DOTT. FORMENTI S.P.A. INDUSTRIA CHIMICA E FARMACEUTICA (IT) | 1990-01-03 | — | — | EP | claimed |